// App-Quantinova.ai

383 : The AdnaCellector, a new fully automated selection for circulating tumor cells in blood of primary and metastatic breast cancer patients

Researchers

Presenter

  • Maren Bredemeier

Principal Investigators

  • Natalie Fenjuk

  • Siegfried Hauch

  • Bahriye Aktas

  • Mitra Tewes

  • Rainer Kimmig

  • Sabine Kasimir-Bauer

Medical Centers

  • Department of Surgery, Westgerman Cancer Center, University Hospital Essen, Essen, Germany

  • Department of Gynecology and Obstetrics, University Hospital Dresden, Dresden, Germany

  • AdnaGen, Langenhagen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Cancer antigen 15-3

  • Circulating tumor cells

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved